can glp-1 cause joint pain Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling Supremo Nutrition | Diabetes Management

The Food and Drug Administration (FDA) has approved Eli Lillys once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problems

The population in Lillys latest trial consisted of adults with type 2 diabetes, a group that historically sees less weight loss than those without

The mice underwent a week of acclimation through handling before any measurements were taken

Pancreatic Safety and Pancreatitis Risk Pancreatitis has been reported in some people taking GLP-1 medications, though it is rare

The primary consideration for injection timing relates to side effect management rather than drug efficacy

Law Enforcement Officers Offering Accident Reconstruction Opinions are Subject To Daubert Scrutiny In automotive product liability cases, accident reconstructionists can play a vital role in showing the who, what, when, where, why, and how of a given wreck